TargEar – general information


Project title: Active targeted drug delivery systems based on peptide-functionalized magnetic nanoparticles for the treatment of inner ear diseases (TargEar)

Code: RO-NO-2019-0187


Promoter“Apollonia” University of Iasi, Romania

Partners:  P1 – Institute of Biological Research – INCDSB, Iasi, Romania

P2 – University of Oslo, Norway

Funding: Norway Grants NO 2014-2021 and the Government of Romania

Name of the ProgramResearch – RO 02

Program OperatorExecutive Agency for Higher Education, Research, Development and Innovation Funding (UEFISCDI)

Total value of public funding: 1.163.984 euro (5.624.137,90 Lei)

Project start date: 01.09.2020

Project duration: 36 months


Norway Grants

The European Economic Area (EEA) and Norway Grants represent the contribution of Iceland, Liechtenstein and Norway to reducing economic and social disparities in the European Economic Area and to strengthening bilateral relations with the 15 beneficiary countries in Eastern and Southern Europe and the Baltic states.

These financial mechanisms are based on the European Economic Area Agreement which reunites the EU member states and Iceland, Liechtenstein and Norway as equal partners in the internal market.

In total, the three countries have provided €3.3 billion through consecutive grant schemes between 1994 and 2014. A further €2.8 billion has been made available in the 2014-2021 funding period. The EEA grants are jointly funded by all the three donors, while the Norway Grants are funded exclusively by Norway and are available in the 13 countries having joined the EU after 2003.

Funding is channelled through financing programmes, under specific priority sectors, while the areas, objectives and expected results are established with each beneficiary country.

For more details on the EEA and Norway Grants see www.eeagrants.orgwww.norwaygrants.org and data.eeagrants.org.







Working together for a green, competitive and inclusive Europe